The Administrator announces changes to the Index Methodology for all CF Classification Series indices, and CF Meta Lab Series indices.
The Index Methodology changes are listed below.

These changes will come into effect on Monday November 18th, 2024.
In accordance with the Administrator’s policies, the above changes do not require a consultation.
Questions or queries should be addressed to [email protected].
Any user wishing to file a complaint regarding these changes can do so confidentially by emailing [email protected].
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.
Note: Some of the underlying instruments cited within this material may be restricted to certain customer categories in certain jurisdictions.
Value led CF Benchmarks' factor table for a third straight week at 1.85%, even as its pace cooled. Growth flipped positive while Downside Beta turned negative for the first time in three weeks, and the Market's decline eased sharply to 0.70% from last week's near-5% drop.

Mark Pilipczuk
The Administrator has confirmed changes to the Token Market Price Family for the period 08 September 2026 to 15 September 2026

CF Benchmarks
The CME CF Emerging Crypto Index provides rules-based exposure beyond Bitcoin and Ether, capturing networks that account for most observed protocol fees and user activity while applying the institutional standards required for a credible benchmark.

CF Benchmarks
By clicking Accept, you consent to CF Benchmarks's use of cookies.
Visit Cookie Settings to learn how CF Benchmarks uses cookies and to adjust your preferences.